| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0021-9150(99)00019-2 |
| P698 | PubMed publication ID | 10428300 |
| P50 | author | Anita C. Thomas | Q41919936 |
| Melinda Fitzgerald | Q42339698 | ||
| Ian Hayward | Q48122373 | ||
| P2093 | author name string | G R Campbell | |
| J H Campbell | |||
| P2860 | cites work | Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms | Q71218618 |
| Extracellular matrix collagen synthesis and degradation following coronary balloon angioplasty | Q71328384 | ||
| In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases | Q71468996 | ||
| Assessment of myointimal cellular kinetics in a model of angioplasty by means of proliferating cell nuclear antigen expression | Q71653451 | ||
| Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall | Q71657591 | ||
| Matrix metalloproteinase inhibitors: a novel class of anticancer agents | Q71773749 | ||
| Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm | Q71938798 | ||
| Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation | Q72019019 | ||
| Interstitial Collagenase (MMP-1) Expression in Human Carotid Atherosclerosis | Q72034087 | ||
| Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat | Q72133135 | ||
| Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase | Q72349595 | ||
| Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques | Q72697873 | ||
| Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis | Q72711310 | ||
| Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta | Q73025879 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm | Q28245985 | ||
| Heparanases and tumor metastasis | Q28294717 | ||
| Metalloproteinases and their inhibitors in matrix remodeling | Q28305537 | ||
| Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. | Q34143433 | ||
| Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development | Q34263093 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media | Q34599512 | ||
| Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens | Q36204340 | ||
| Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity | Q36222670 | ||
| The phenotypes of smooth muscle expressed in human atheroma | Q37828359 | ||
| Culture techniques and their applications to studies of vascular smooth muscle | Q40804204 | ||
| Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo | Q41111506 | ||
| Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation | Q42092461 | ||
| Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion | Q42494764 | ||
| Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype | Q42826785 | ||
| Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina | Q46149107 | ||
| Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms | Q46552120 | ||
| Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. | Q54569934 | ||
| Upregulation of Basement Membrane–Degrading Metalloproteinase Secretion After Balloon Injury of Pig Carotid Arteries | Q58009944 | ||
| Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype | Q68095509 | ||
| Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery | Q68339861 | ||
| Metabolism of atherogenic lipoproteins by smooth muscle cells of different phenotype in culture | Q68936620 | ||
| Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state | Q69539714 | ||
| Smooth muscle phenotypic expression in human carotid arteries. II. Atherosclerosis-free diffuse intimal thickenings compared with the media | Q69657551 | ||
| Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor | Q70865447 | ||
| What controls smooth muscle phenotype? | Q71081589 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 97-106 | |
| P577 | publication date | 1999-07-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Matrix metalloproteinase can facilitate the heparanase-induced promotion of phenotype change in vascular smooth muscle cells | |
| P478 | volume | 145 |
| Q39771175 | A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy. |
| Q38680594 | An overview of potential molecular mechanisms involved in VSMC phenotypic modulation |
| Q34051151 | Effect of matrix metalloproteinase-9 knockout on vein graft remodelling in mice |
| Q34455024 | Endogenous heparin activity deficiency: the 'missing link' in atherogenesis? |
| Q24304314 | Heparanase in primary human osteoblasts |
| Q36752653 | Heparanase: a target for drug discovery in cancer and inflammation |
| Q45068673 | Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-alpha through inhibition of matrix metalloproteinase-2 and -9 activity |
| Q53601919 | Inhibitory effect of Salvia miltiorrhia BGE on matrix metalloproteinase-9 activity and migration of TNF-alpha-induced human aortic smooth muscle cells. |
| Q27025052 | Involvement of heparanase in atherosclerosis and other vessel wall pathologies |
| Q36947562 | Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure |
| Q36542354 | Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression |
| Q35007988 | Oxidized lipoproteins and macrophages |
| Q42173811 | Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine |
| Q54567631 | Triple inhibitory activity of Cliona celata against TNF-α-induced matrix metalloproteinase-9 production via downregulated NF-κB and AP-1, enzyme activity, and migration potential. |
| Q34162540 | Trophoblast- and vascular smooth muscle cell-derived MMP-12 mediates elastolysis during uterine spiral artery remodeling |
Search more.